Works matching IS 11707690 AND DT 2024 AND VI 42

Results: 116

An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?

Published in:

PharmacoEconomics, 2024, v. 42, n. 12, p. 1395, doi. 10.1007/s40273-024-01429-0

By:

Latimer, Nicholas R.;
Taylor, Kurt;
Hatswell, Anthony J.;
Ho, Sophia;
Okorogheye, Gabriel;
Chen, Clara;
Kim, Inkyu;
Borrill, John;
Bertwistle, David

Publication type:

Article

Incorporating Complexity and System Dynamics into Economic Modelling for Mental Health Policy and Planning.

Published in:

PharmacoEconomics, 2024, v. 42, n. 12, p. 1301, doi. 10.1007/s40273-024-01434-3

By:

Crosland, Paul;
Marshall, Deborah A.;
Hosseini, Seyed Hossein;
Ho, Nicholas;
Vacher, Catherine;
Skinner, Adam;
Nguyen, Kim-Huong;
Iorfino, Frank;
Rosenberg, Sebastian;
Song, Yun Ju Christine;
Tsiachristas, Apostolos;
Tran, Kristen;
Occhipinti, Jo-An;
Hickie, Ian B.

Publication type:

Article

Valuation of the EORTC Quality of Life Utility Core 10 Dimensions (QLU-C10D) in a Multi-ethnic Asian Setting: How Does Having Cancer Matter?

Published in:

PharmacoEconomics, 2024, v. 42, n. 12, p. 1413, doi. 10.1007/s40273-024-01432-5

By:

Gandhi, Mihir;
Kanesvaran, Ravindran;
Rashid, Mohamad Farid Bin Harunal;
Chong, Dawn Qingqing;
Chay, Wen-Yee;
Tan, Rachel Lee-Yin;
Norman, Richard;
King, Madeleine T.;
Luo, Nan

Publication type:

Article

Different Models, Same Results: Considerations When Choosing Between Approaches to Model Cost Effectiveness of Chimeric-Antigen Receptor T-Cell Therapy Versus Standard of Care.

Published in:

PharmacoEconomics, 2024, v. 42, n. 12, p. 1359, doi. 10.1007/s40273-024-01430-7

By:

Gye, Amy;
De Abreu Lourenco, Richard;
Goodall, Stephen

Publication type:

Article

Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review.

Published in:

PharmacoEconomics, 2024, v. 42, n. 12, p. 1329, doi. 10.1007/s40273-024-01428-1

By:

Antonazzo, Ippazio Cosimo;
Gribaudo, Giorgia;
La Vecchia, Adriano;
Ferrara, Pietro;
Piraino, Alexandra;
Cortesi, Paolo Angelo;
Mantovani, Lorenzo Giovanni

Publication type:

Article

MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation—A Tutorial.

Published in:

PharmacoEconomics, 2024, v. 42, n. 12, p. 1317, doi. 10.1007/s40273-024-01425-4

By:

Bullement, Ash;
Edmondson-Jones, Mark;
Guyot, Patricia;
Welton, Nicky J.;
Baio, Gianluca;
Stevenson, Matthew;
Latimer, Nicholas R.

Publication type:

Article

Effects and Costs of Hepatitis C Virus Elimination for the Whole Population in China: A Modelling Study.

Published in:

PharmacoEconomics, 2024, v. 42, n. 12, p. 1345, doi. 10.1007/s40273-024-01424-5

By:

Wu, Meiyu;
Ma, Jing;
Li, Sini;
Qin, Shuxia;
Tan, Chongqing;
Xie, Ouyang;
Li, Andong;
Lim, Aaron G.;
Wan, Xiaomin

Publication type:

Article

Evidence Following Conditional NICE Technology Appraisal Recommendations: A Critical Analysis of Methods, Quality and Risk of Bias.

Published in:

PharmacoEconomics, 2024, v. 42, n. 12, p. 1373, doi. 10.1007/s40273-024-01418-3

By:

Pijeira Perez, Yankier;
Hughes, Dyfrig A.

Publication type:

Article

Drug Pricing Stewardship from Mark Cuban's Cost Plus Generic Drug Program.

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1279, doi. 10.1007/s40273-024-01426-3

By:

Gulati, Snigdha;
Gupta, Mohak;
Yan, TingTing;
Yelamanchili, Sneha;
Xu, Lucy Qinghua;
Bharani, Tina;
Naji, Ali;
Agarwal, Divyansh

Publication type:

Article

Treatment Effect Waning in Immuno-oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence with Proposals to Guide Modelling.

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1181, doi. 10.1007/s40273-024-01423-6

By:

Taylor, Kurt;
Latimer, Nicholas R.;
Douglas, Thomas;
Hatswell, Anthony J.;
Ho, Sophia;
Okorogheye, Gabriel;
Borril, John;
Chen, Clara;
Kim, Inkyu;
Bertwistle, David

Publication type:

Article

Delaying Oral Anticoagulants: A False Economy?

Published in:

2024

By:

Collins, Brendan;
Lip, Gregory Y. H.

Publication type:

Letter

Using Cure Modelling for Cost Effectiveness in the NICE Technology Appraisal of Polatuzumab Vedotin in Combination for Untreated Diffuse Large B Cell Lymphoma: An External Assessment Group Perspective.

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1177, doi. 10.1007/s40273-024-01421-8

By:

Cooper, Keith;
Maund, Emma;
Takahashi, Marcia Tomie;
Shepherd, Jonathan

Publication type:

Article

Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses.

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1209, doi. 10.1007/s40273-024-01410-x

By:

Tomeny, Ewan M.;
Hampton, Thomas;
Tran, Phuong Bich;
Rosu, Laura;
Phiri, Mphatso D.;
Haigh, Kathryn A.;
Nidoi, Jasper;
Wingfield, Tom;
Worrall, Eve

Publication type:

Article

Delay and Pay? Healthcare Costs Associated with Late Oral Anti-coagulant Prescribing in People with Atrial Fibrillation.

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1241, doi. 10.1007/s40273-024-01419-2

By:

Mulholland, Ryan J.;
Ciminata, Giorgio;
Quinn, Terry J.;
Pollock, Kevin G.;
Lister, Steven;
Geue, Claudia

Publication type:

Article

Empirical Testing of Alternative Search Methods to Retrieve Utility Values for Health Economic Modelling.

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1255, doi. 10.1007/s40273-024-01414-7

By:

Lister, Johanna;
Paisley, Suzy;
Carroll, Christopher;
Tappenden, Paul

Publication type:

Article

Considerations Around the Inclusion of Children and Young People's Time in Economic Evaluation: Findings from an International Delphi Study.

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1267, doi. 10.1007/s40273-024-01411-w

By:

Morgan, Cameron;
Donaldson, Cam;
Lancsar, Emily;
Petrou, Stavros;
Andronis, Lazaros

Publication type:

Article

Improving Transparency of Decision Models Through the Application of Decision Analytic Models with Omitted Objects Displayed (DAMWOOD).

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1197, doi. 10.1007/s40273-024-01401-y

By:

Round, Jeff;
Kirwin, Erin;
van Katwyk, Sasha;
McCabe, Christopher

Publication type:

Article

Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee.

Published in:

PharmacoEconomics, 2024, v. 42, n. 11, p. 1287, doi. 10.1007/s40273-024-01420-9

By:

Tirrell, Zachary;
Norman, Alicia;
Hoyle, Martin;
Lybrand, Sean;
Parkinson, Bonny

Publication type:

Article

A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist.

Published in:

PharmacoEconomics, 2024, v. 42, n. 10, p. 1161, doi. 10.1007/s40273-024-01431-6

By:

Ride, Jemimah;
Goranitis, Ilias;
Meng, Yan;
LaBond, Christine;
Lancsar, Emily

Publication type:

Article

Unravelling Elements of Value of Healthcare and Assessing their Importance Using Evidence from Two Discrete-Choice Experiments in England.

Published in:

PharmacoEconomics, 2024, v. 42, n. 10, p. 1145, doi. 10.1007/s40273-024-01416-5

By:

Gongora-Salazar, Pamela;
Perera, Rafael;
Rivero-Arias, Oliver;
Tsiachristas, Apostolos

Publication type:

Article

Proxy Preferences and the Values of Children's Health States.

Published in:

PharmacoEconomics, 2024, v. 42, n. 10, p. 1065, doi. 10.1007/s40273-024-01415-6

By:

Hausman, Daniel M.

Publication type:

Article

Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer.

Published in:

PharmacoEconomics, 2024, v. 42, n. 10, p. 1091, doi. 10.1007/s40273-024-01413-8

By:

Sharma, Shikha;
Carey, Niamh;
McConnell, David;
Lowery, Maeve;
O'Sullivan, Jacintha;
McCullagh, Laura

Publication type:

Article

Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission–Economic Evaluation Model.

Published in:

PharmacoEconomics, 2024, v. 42, n. 10, p. 1111, doi. 10.1007/s40273-024-01412-9

By:

Jiang, Yawen;
Wen, Jiaxin;
Sun, Jiatong;
Shu, Yuelong

Publication type:

Article

Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know.

Published in:

PharmacoEconomics, 2024, v. 42, n. 10, p. 1073, doi. 10.1007/s40273-024-01406-7

By:

Latimer, Nicholas R.;
Rutherford, Mark J.

Publication type:

Article

Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework.

Published in:

PharmacoEconomics, 2024, v. 42, n. 10, p. 1127, doi. 10.1007/s40273-024-01400-z

By:

Scott II, R. Douglas;
Culler, Steven D.;
Baggs, James;
Reddy, Sujan C.;
Slifka, Kara Jacobs;
Magill, Shelley S.;
Kazakova, Sophia V.;
Jernigan, John A.;
Nelson, Richard E.;
Rosenman, Robert E.;
Wandschneider, Philip R.

Publication type:

Article

Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 1029, doi. 10.1007/s40273-024-01409-4

By:

Sutton, Andrew J.;
Lupu, Daniel S.;
Bergin, Stephen P.;
Holland, Thomas L.;
McAdams, Staci A.;
Dadwal, Sanjeet S.;
Nguyen, Khoi;
Nolte, Frederick S.;
Tremblay, Gabriel;
Perkins, Bradley A.

Publication type:

Article

NICE Approaches to Expert Opinion Evidence in Highly Specialised Technologies: Time to Change? Evidence Assessment Group Perspective.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 913, doi. 10.1007/s40273-024-01405-8

By:

Moradi, Najmeh;
O'Connor, Nicole;
Thomson, Katie H.;
Shabaninejad, Hosein;
Sotire, Tumi;
Still, Madeleine;
Fernandez-Garcia, Cristina;
Wallace, Sheila A.;
Williams, Oleta;
Vale, Luke;
Sagoo, Gurdeep S.

Publication type:

Article

Estimating an EQ-5D-Y-3L Value Set for Brazil.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 1047, doi. 10.1007/s40273-024-01404-9

By:

Espirito Santo, Caique Melo;
Miyamoto, Gisela Cristiane;
Santos, Verônica Souza;
Ben, Ângela Jornada;
Finch, Aureliano Paolo;
Roudijk, Bram;
de Jesus-Moraleida, Fabianna Resende;
Stein, Airton Tetelbom;
Santos, Marisa;
Yamato, Tiê Parma

Publication type:

Article

A Systematic Review of Methods and Practice for Integrating Maternal, Fetal, and Child Health Outcomes, and Family Spillover Effects into Cost-Utility Analyses.

Published in:

PharmacoEconomics, 2024, v. 42, n. 8, p. 843, doi. 10.1007/s40273-024-01397-5

By:

Lamsal, Ramesh;
Yeh, E. Ann;
Pullenayegum, Eleanor;
Ungar, Wendy J.

Publication type:

Article

Rapid Assessment of the Need for Evidence: Applying the Principles of Value of Information to Research Prioritisation.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 919, doi. 10.1007/s40273-024-01403-w

By:

Glynn, David;
Gc, Vijay S.;
Claxton, Karl;
Littlewood, Chris;
Rothery, Claire

Publication type:

Article

Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 1017, doi. 10.1007/s40273-024-01398-4

By:

Gao, Ni;
Dakin, Helen A.;
Holman, Rury R.;
Lim, Lee-Ling;
Leal, José;
Clarke, Philip

Publication type:

Article

Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 929, doi. 10.1007/s40273-024-01388-6

By:

de Jong, Lisa A.;
Li, Xinyu;
Emamipour, Sajad;
van der Werf, Sjoukje;
Postma, Maarten J.;
van Dijk, Peter R.;
Feenstra, Talitha L.

Publication type:

Article

A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health Technologies.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 1003, doi. 10.1007/s40273-024-01395-7

By:

Tappenden, Paul;
Hardiman, Orla;
Kwon, Sun-Hong;
Mon-Yee, Mon;
Galvin, Miriam;
McDermott, Christopher

Publication type:

Article

A Systematic Review of Methods for Estimating Productivity Losses due to Illness or Caregiving in Low- and Middle-Income Countries.

Published in:

PharmacoEconomics, 2024, v. 42, n. 8, p. 865, doi. 10.1007/s40273-024-01402-x

By:

Setiawan, Ery;
Cassidy-Seyoum, Sarah A.;
Thriemer, Kamala;
Carvalho, Natalie;
Devine, Angela

Publication type:

Article

A Systematic Review of Modeling Approaches to Evaluate Treatments for Relapsed Refractory Multiple Myeloma: Critical Review and Considerations for Future Health Economic Models.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 955, doi. 10.1007/s40273-024-01399-3

By:

Freitag, Andreas;
Sarri, Grammati;
Ta, An;
Gurskyte, Laura;
Cherepanov, Dasha;
Hernandez, Luis G.

Publication type:

Article

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

Published in:

PharmacoEconomics, 2024, v. 42, n. 8, p. 829, doi. 10.1007/s40273-024-01394-8

By:

Scholte, Mirre;
Ramaekers, Bram;
Danopoulos, Evangelos;
Grimm, Sabine E.;
Fernandez Coves, Andrea;
Tian, Xiaoyu;
Debray, Thomas;
Chen, Jiongyu;
Stirk, Lisa;
Croft, Rachel;
Joore, Manuela;
Armstrong, Nigel

Publication type:

Article

PharmacoEconomics Supplement: Advancing methods to measure and reward healthcare innovation: results from the valuing innovation project.

Published in:: 2024
Publication type:: Announcement

Could or Should We Use Cost-Effectiveness Thresholds in the French Value-Based Pricing Process for New Drugs?

Published in:

2024

By:

Ghabri, Salah

Publication type:

Editorial

Examining the Effect of Depicting a Patient Affected by a Negative Reimbursement Decision in Healthcare on Public Disagreement with the Decision.

Published in:

PharmacoEconomics, 2024, v. 42, n. 8, p. 879, doi. 10.1007/s40273-024-01386-8

By:

de Bruijn, Anne;
van Don, Mats;
Knies, Saskia;
Brouwer, Werner;
Reckers-Droog, Vivian

Publication type:

Article

The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment.

Published in:

PharmacoEconomics, 2024, v. 42, p. 187, doi. 10.1007/s40273-024-01396-6

By:

McElwee, Frederick;
Newall, Anthony

Publication type:

Article

A Prototype Software Framework for Transferable Computational Health Economic Models and Its Early Application in Youth Mental Health.

Published in:

PharmacoEconomics, 2024, v. 42, n. 8, p. 833, doi. 10.1007/s40273-024-01378-8

By:

Hamilton, Matthew P.;
Gao, Caroline;
Wiesner, Glen;
Filia, Kate M.;
Menssink, Jana M.;
Plencnerova, Petra;
Baker, David G.;
McGorry, Patrick D.;
Parker, Alexandra;
Karnon, Jonathan;
Cotton, Sue M.;
Mihalopoulos, Cathrine

Publication type:

Article

Advancing Methods to Measure and Reward Healthcare Innovation.

Published in:

2024

By:

Chapman, Richard;
Xie, Richard

Publication type:

Editorial

Correction to: Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries

Published in:

2024

By:

Panattoni, Laura;
Kearney, Mairead;
Land, Natalie;
Flottemesch, Thomas;
Sullivan, Patrick;
Kirker, Melissa;
Bharmal, Murtuza;
Hauber, Brett

Publication type:

Correction Notice

Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework.

Published in:

PharmacoEconomics, 2024, v. 42, p. 211, doi. 10.1007/s40273-024-01392-w

By:

Ali, Askal Ayalew;
Kulkarni, Amit;
Bhattacharjee, Sandipan;
Diaby, Vakaramoko

Publication type:

Article

Incorporating Real Option Value in Valuing Innovation: A Way Forward.

Published in:

PharmacoEconomics, 2024, v. 42, p. 199, doi. 10.1007/s40273-024-01352-4

By:

Li, Meng;
Garrison, Louis P.

Publication type:

Article

Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries

Published in:

PharmacoEconomics, 2024, v. 42, n. 8, p. 895, doi. 10.1007/s40273-024-01359-x

By:

Panattoni, Laura;
Kearney, Mairead;
Land, Natalie;
Flottemesch, Thomas;
Sullivan, Patrick;
Kirker, Melissa;
Bharmal, Murtuza;
Hauber, Brett

Publication type:

Article

Cost-of-Illness of Skin Cancer: A Systematic Review.

Published in:

PharmacoEconomics, 2024, v. 42, n. 7, p. 751, doi. 10.1007/s40273-024-01389-5

By:

Meertens, Annick;
Van Coile, Laura;
Van Iseghem, Tijs;
Brochez, Lieve;
Verhaeghe, Nick;
Hoorens, Isabelle

Publication type:

Article

Exploring the Use of Pictorial Approaches in the Development of Paediatric Patient-Reported Outcome Instruments: A Systematic Review.

Published in:

PharmacoEconomics, 2024, v. 42, p. 9, doi. 10.1007/s40273-024-01357-z

By:

Mpundu-Kaambwa, Christine;
Bulamu, Norma B.;
Lines, Lauren;
Chen, Gang;
Whitehurst, David G. T.;
Dalziel, Kim;
Devlin, Nancy;
Ratcliffe, Julie

Publication type:

Article

Correction: Comparing the Psychometric Performance of Generic Paediatric Health‑Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.

Published in:

PharmacoEconomics, 2024, v. 42, p. 79, doi. 10.1007/s40273-024-01373-z

By:

O'Loughlin, Rachel;
Jones, Renee;
Chen, Gang;
Mulhern, Brendan;
Hiscock, Harriet;
Devlin, Nancy;
Dalziel, Kim

Publication type:

Article

A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.

Published in:

PharmacoEconomics, 2024, v. 42, p. 95, doi. 10.1007/s40273-024-01379-7

By:

Bahrampour, Mina;
Devlin, Nancy;
Jones, Renee;
Dalziel, Kim;
Mulhern, Brendan

Publication type:

Article